← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2008Last known activity
Aug 20, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 5 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (9)
- NCT06440629CollaboratorPhase 4Aug 20, 2024
- NCT06084364OfficialPhase 4Nov 3, 2023
- NCT06084364CollaboratorPhase 4Nov 3, 2023
- NCT06084364Overall official - principal investigatorPhase 4Nov 3, 2023
- NCT05306548CollaboratorPhase 4Apr 8, 2022
- NCT04303026Lead sponsorPhase 3Mar 2, 2020
- NCT04303026Reponsible party - principal investigatorPhase 3Mar 2, 2020
- NCT01714297Lead sponsorPhase 4Jan 1, 2008
- NCT01714297Reponsible party - principal investigatorPhase 4Jan 1, 2008
Details
- Last known activity
- Aug 20, 2024